Selected vaccine-industry incubation projects delivered or under execution. Every completed project has passed the customer's GMP acceptance — the same validation standard used by biopharma plants worldwide.
| Client | Year | GMP status |
|---|---|---|
| Shangqiu Meilan Biology Co., Ltd. (China) | 2025 | Passed |
| Guangzhou SCAU Biological Products Co., Ltd. (China) | 2021 | Passed |
| Shanxi Longkeer Biopharmaceutical Co., Ltd. (China) | 2022 | Passed |
| Zhejiang Dingchi Biological Products Co., Ltd. (China) | 2023 | Passed |
| Guangdong Huasheng Biotechnology Co., Ltd. (China) | 2024 | Passed |
| UBC Fine Biopharmaceuticals (Vietnam) | 2025 | Passed |
| Shanxi Weierfu Biotechnology Co., Ltd. (China) | 2025 | In progress |
| Shijiazhuang Shengao Biotechnology Co., Ltd. (China) | 2026 | In progress |
| Thuan Thien Machinery Equipment JSC (Vietnam) | 2026 | In progress |
| Medion Animal Health JSC (Vietnam) | 2026 | In progress |
| OGV Biotec LLC (Oman) | 2026 | In progress |
Get a tailored equipment proposal within 24 hours.